| 0.8 |
3.1 |
GO:0060715 |
syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
| 0.6 |
1.9 |
GO:0021649 |
vestibulocochlear nerve morphogenesis(GO:0021648) vestibulocochlear nerve structural organization(GO:0021649) ganglion morphogenesis(GO:0061552) dorsal root ganglion morphogenesis(GO:1904835) |
| 0.6 |
1.9 |
GO:1901254 |
positive regulation of intracellular transport of viral material(GO:1901254) |
| 0.6 |
2.5 |
GO:0070425 |
negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
| 0.6 |
1.8 |
GO:0070671 |
activation of meiosis involved in egg activation(GO:0060466) response to interleukin-12(GO:0070671) positive regulation of acrosome reaction(GO:2000344) |
| 0.6 |
1.8 |
GO:0060785 |
regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
| 0.5 |
5.4 |
GO:0090232 |
positive regulation of spindle checkpoint(GO:0090232) |
| 0.5 |
0.5 |
GO:2000314 |
negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.5 |
0.5 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.5 |
3.1 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.5 |
1.4 |
GO:0070476 |
rRNA (guanine-N7)-methylation(GO:0070476) |
| 0.5 |
2.3 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.4 |
1.7 |
GO:0061428 |
embryonic heart tube left/right pattern formation(GO:0060971) negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.4 |
1.3 |
GO:0016344 |
meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.4 |
1.2 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 0.4 |
0.8 |
GO:0071139 |
resolution of recombination intermediates(GO:0071139) |
| 0.4 |
1.1 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.4 |
1.8 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.4 |
1.4 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.4 |
2.5 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.4 |
1.8 |
GO:0046684 |
response to pyrethroid(GO:0046684) |
| 0.4 |
1.1 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.3 |
1.0 |
GO:2000834 |
androgen secretion(GO:0035935) testosterone secretion(GO:0035936) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.3 |
1.0 |
GO:0010751 |
regulation of arginine metabolic process(GO:0000821) negative regulation of nitric oxide mediated signal transduction(GO:0010751) negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 0.3 |
1.3 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.3 |
1.6 |
GO:0001302 |
replicative cell aging(GO:0001302) |
| 0.3 |
0.6 |
GO:1900453 |
negative regulation of long term synaptic depression(GO:1900453) |
| 0.3 |
1.3 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.3 |
1.6 |
GO:0050651 |
dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.3 |
1.2 |
GO:0086042 |
cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 0.3 |
0.3 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.3 |
1.5 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.3 |
0.9 |
GO:1904431 |
positive regulation of t-circle formation(GO:1904431) |
| 0.3 |
0.9 |
GO:0090529 |
barrier septum assembly(GO:0000917) cell septum assembly(GO:0090529) |
| 0.3 |
4.8 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.3 |
1.1 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.3 |
0.8 |
GO:1902277 |
negative regulation of pancreatic amylase secretion(GO:1902277) |
| 0.3 |
0.8 |
GO:0070124 |
mitochondrial translational initiation(GO:0070124) |
| 0.3 |
1.1 |
GO:2000812 |
regulation of barbed-end actin filament capping(GO:2000812) |
| 0.3 |
0.5 |
GO:0019086 |
late viral transcription(GO:0019086) |
| 0.3 |
0.8 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.3 |
0.8 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.3 |
0.3 |
GO:1901668 |
regulation of superoxide dismutase activity(GO:1901668) |
| 0.2 |
1.2 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.2 |
1.2 |
GO:1903347 |
negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.2 |
0.7 |
GO:0035790 |
platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
| 0.2 |
2.1 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.2 |
0.5 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 0.2 |
1.1 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.2 |
2.5 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 0.2 |
7.6 |
GO:0060074 |
synapse maturation(GO:0060074) |
| 0.2 |
0.9 |
GO:0018307 |
enzyme active site formation(GO:0018307) |
| 0.2 |
0.7 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
| 0.2 |
0.6 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.2 |
1.3 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.2 |
0.6 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.2 |
1.0 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.2 |
0.6 |
GO:2000302 |
regulation of synaptic vesicle endocytosis(GO:1900242) positive regulation of synaptic vesicle exocytosis(GO:2000302) |
| 0.2 |
0.6 |
GO:0046881 |
sperm ejaculation(GO:0042713) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
| 0.2 |
1.2 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.2 |
0.6 |
GO:0017085 |
response to insecticide(GO:0017085) |
| 0.2 |
0.8 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.2 |
0.8 |
GO:0043651 |
linoleic acid metabolic process(GO:0043651) |
| 0.2 |
1.5 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.2 |
0.7 |
GO:0046898 |
response to cycloheximide(GO:0046898) |
| 0.2 |
2.3 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) |
| 0.2 |
0.7 |
GO:0061010 |
gall bladder development(GO:0061010) |
| 0.2 |
0.9 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.2 |
0.5 |
GO:2000686 |
regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.2 |
0.7 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.2 |
0.5 |
GO:1903774 |
positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.2 |
1.0 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.2 |
0.7 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.2 |
0.7 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.2 |
2.8 |
GO:0006266 |
DNA ligation(GO:0006266) |
| 0.2 |
1.1 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 0.2 |
1.6 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.2 |
0.3 |
GO:1903772 |
regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.2 |
1.1 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.2 |
1.8 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 |
0.6 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.1 |
0.7 |
GO:0051006 |
positive regulation of lipoprotein lipase activity(GO:0051006) |
| 0.1 |
0.4 |
GO:1902774 |
late endosome to lysosome transport(GO:1902774) |
| 0.1 |
0.9 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.1 |
2.6 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.1 |
0.7 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.1 |
1.1 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.1 |
0.7 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.1 |
1.9 |
GO:0007095 |
mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.1 |
0.3 |
GO:1901727 |
regulation of histone deacetylase activity(GO:1901725) positive regulation of histone deacetylase activity(GO:1901727) |
| 0.1 |
1.7 |
GO:1901898 |
negative regulation of relaxation of muscle(GO:1901078) regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.1 |
0.8 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.1 |
1.7 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.1 |
0.6 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.1 |
0.4 |
GO:1904457 |
positive regulation of neuronal action potential(GO:1904457) |
| 0.1 |
4.2 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.1 |
6.2 |
GO:0047496 |
vesicle transport along microtubule(GO:0047496) |
| 0.1 |
0.9 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.1 |
0.2 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.1 |
0.4 |
GO:0060046 |
regulation of acrosome reaction(GO:0060046) |
| 0.1 |
0.9 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.1 |
0.2 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.1 |
0.7 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.1 |
1.1 |
GO:0036371 |
T-tubule organization(GO:0033292) protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
| 0.1 |
0.8 |
GO:0014053 |
negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
| 0.1 |
0.8 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.1 |
0.6 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.1 |
0.3 |
GO:0070488 |
neutrophil aggregation(GO:0070488) |
| 0.1 |
0.2 |
GO:0021886 |
hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
| 0.1 |
0.8 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.1 |
0.2 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.1 |
2.4 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.1 |
0.5 |
GO:0007197 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.1 |
0.3 |
GO:0043201 |
response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
| 0.1 |
0.8 |
GO:0045213 |
neurotransmitter receptor metabolic process(GO:0045213) |
| 0.1 |
0.5 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
| 0.1 |
0.8 |
GO:0031848 |
protection from non-homologous end joining at telomere(GO:0031848) |
| 0.1 |
0.5 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.1 |
0.9 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.1 |
1.0 |
GO:0006691 |
leukotriene metabolic process(GO:0006691) |
| 0.1 |
1.6 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.1 |
0.2 |
GO:0048294 |
negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.1 |
2.3 |
GO:0006054 |
N-acetylneuraminate metabolic process(GO:0006054) |
| 0.1 |
0.3 |
GO:0048611 |
ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
| 0.1 |
0.4 |
GO:0055071 |
cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
| 0.1 |
0.3 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.1 |
1.0 |
GO:0016559 |
peroxisome fission(GO:0016559) |
| 0.1 |
0.5 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.1 |
0.6 |
GO:0070072 |
vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.1 |
1.3 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
| 0.1 |
0.3 |
GO:1903546 |
protein localization to photoreceptor outer segment(GO:1903546) |
| 0.1 |
0.5 |
GO:0090399 |
replicative senescence(GO:0090399) |
| 0.1 |
0.1 |
GO:2000017 |
positive regulation of determination of dorsal identity(GO:2000017) |
| 0.1 |
0.4 |
GO:0031509 |
telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.1 |
0.5 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.1 |
1.0 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.1 |
0.4 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.1 |
0.3 |
GO:0097296 |
activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.1 |
0.4 |
GO:0071105 |
response to interleukin-11(GO:0071105) osteoclast fusion(GO:0072675) |
| 0.1 |
2.0 |
GO:0072583 |
clathrin-mediated endocytosis(GO:0072583) |
| 0.1 |
1.4 |
GO:0030574 |
collagen catabolic process(GO:0030574) |
| 0.1 |
0.3 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.1 |
0.3 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.1 |
0.5 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.1 |
0.3 |
GO:0097484 |
dendrite extension(GO:0097484) |
| 0.1 |
0.4 |
GO:1900016 |
negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.1 |
0.2 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.1 |
0.2 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.1 |
1.1 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 0.1 |
0.7 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.1 |
0.4 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.1 |
0.1 |
GO:0036115 |
fatty-acyl-CoA catabolic process(GO:0036115) |
| 0.1 |
0.6 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.1 |
0.2 |
GO:0002002 |
regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
| 0.1 |
0.2 |
GO:0071638 |
negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
| 0.1 |
0.5 |
GO:0001771 |
immunological synapse formation(GO:0001771) |
| 0.1 |
0.1 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 0.1 |
0.3 |
GO:0090024 |
negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
| 0.1 |
0.2 |
GO:2000152 |
regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) regulation of ubiquitin-specific protease activity(GO:2000152) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.1 |
0.6 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.1 |
0.3 |
GO:0009212 |
dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
| 0.1 |
0.1 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.1 |
0.7 |
GO:1901673 |
regulation of mitotic spindle assembly(GO:1901673) |
| 0.1 |
0.4 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 0.1 |
0.7 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.1 |
0.1 |
GO:0072674 |
multinuclear osteoclast differentiation(GO:0072674) |
| 0.1 |
0.9 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.1 |
0.3 |
GO:0035743 |
CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
| 0.1 |
0.9 |
GO:0006903 |
vesicle targeting(GO:0006903) |
| 0.1 |
0.3 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.1 |
1.4 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.1 |
0.5 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.1 |
0.2 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.1 |
0.6 |
GO:1904424 |
regulation of GTP binding(GO:1904424) |
| 0.1 |
0.3 |
GO:1903071 |
positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.1 |
2.1 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
| 0.1 |
0.3 |
GO:2001268 |
negative regulation of histone H3-K9 dimethylation(GO:1900110) negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.1 |
0.2 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.1 |
1.1 |
GO:0060213 |
regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.1 |
0.3 |
GO:0042117 |
monocyte activation(GO:0042117) |
| 0.1 |
1.4 |
GO:0061099 |
negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.1 |
0.6 |
GO:0060837 |
blood vessel endothelial cell differentiation(GO:0060837) |
| 0.1 |
0.6 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.1 |
0.9 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.1 |
0.5 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.1 |
0.5 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.1 |
0.2 |
GO:1903215 |
regulation of mRNA modification(GO:0090365) negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.1 |
0.5 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.1 |
0.2 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 0.1 |
1.2 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.1 |
0.4 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.1 |
0.6 |
GO:1903963 |
arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.1 |
0.8 |
GO:0048505 |
regulation of timing of cell differentiation(GO:0048505) |
| 0.1 |
0.5 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.1 |
0.9 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.1 |
0.2 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 |
0.1 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.1 |
0.5 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.1 |
0.3 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.1 |
0.7 |
GO:0010763 |
positive regulation of fibroblast migration(GO:0010763) |
| 0.1 |
0.3 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.1 |
0.3 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.1 |
0.1 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.0 |
2.2 |
GO:0032410 |
negative regulation of transporter activity(GO:0032410) |
| 0.0 |
0.5 |
GO:0030049 |
muscle filament sliding(GO:0030049) |
| 0.0 |
1.8 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.0 |
0.5 |
GO:2000096 |
positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.0 |
0.3 |
GO:1901030 |
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
| 0.0 |
0.3 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.0 |
0.1 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.0 |
0.4 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.0 |
0.7 |
GO:0042759 |
long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.0 |
0.3 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.0 |
0.5 |
GO:1904152 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) regulation of retrograde protein transport, ER to cytosol(GO:1904152) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.0 |
0.8 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.0 |
0.4 |
GO:0045136 |
development of secondary sexual characteristics(GO:0045136) |
| 0.0 |
0.1 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.0 |
0.6 |
GO:1902855 |
regulation of nonmotile primary cilium assembly(GO:1902855) positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.0 |
0.3 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.0 |
0.3 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.0 |
0.6 |
GO:0060218 |
hematopoietic stem cell differentiation(GO:0060218) |
| 0.0 |
0.7 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.0 |
0.4 |
GO:0031573 |
intra-S DNA damage checkpoint(GO:0031573) |
| 0.0 |
0.2 |
GO:1903020 |
positive regulation of glycoprotein metabolic process(GO:1903020) |
| 0.0 |
0.7 |
GO:0032755 |
positive regulation of interleukin-6 production(GO:0032755) |
| 0.0 |
0.4 |
GO:0021554 |
optic nerve development(GO:0021554) |
| 0.0 |
0.2 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
| 0.0 |
0.1 |
GO:0007403 |
glial cell fate determination(GO:0007403) |
| 0.0 |
0.5 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.0 |
0.2 |
GO:0021993 |
initiation of neural tube closure(GO:0021993) |
| 0.0 |
0.3 |
GO:0045187 |
regulation of circadian sleep/wake cycle, sleep(GO:0045187) circadian sleep/wake cycle, sleep(GO:0050802) |
| 0.0 |
0.8 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.0 |
0.3 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.0 |
0.2 |
GO:0031442 |
positive regulation of mRNA 3'-end processing(GO:0031442) |
| 0.0 |
0.2 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.0 |
0.1 |
GO:1904263 |
positive regulation of TORC1 signaling(GO:1904263) |
| 0.0 |
0.3 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.0 |
0.5 |
GO:0002063 |
chondrocyte development(GO:0002063) |
| 0.0 |
1.8 |
GO:0048278 |
vesicle docking(GO:0048278) |
| 0.0 |
0.6 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.0 |
0.7 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.0 |
0.3 |
GO:1904321 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.0 |
0.1 |
GO:0045652 |
regulation of megakaryocyte differentiation(GO:0045652) negative regulation of megakaryocyte differentiation(GO:0045653) negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
| 0.0 |
0.2 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.0 |
0.9 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.0 |
0.9 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 |
0.5 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.0 |
0.2 |
GO:0008214 |
protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
| 0.0 |
0.5 |
GO:2000505 |
regulation of energy homeostasis(GO:2000505) |
| 0.0 |
1.1 |
GO:0007257 |
activation of JUN kinase activity(GO:0007257) |
| 0.0 |
0.2 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.0 |
0.6 |
GO:0035518 |
histone H2A monoubiquitination(GO:0035518) |
| 0.0 |
0.6 |
GO:0032933 |
response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.0 |
0.2 |
GO:0010730 |
negative regulation of hydrogen peroxide metabolic process(GO:0010727) negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.0 |
0.7 |
GO:0045725 |
positive regulation of glycogen biosynthetic process(GO:0045725) |
| 0.0 |
0.7 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.0 |
0.4 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.0 |
0.1 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.0 |
0.3 |
GO:1902285 |
semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) |
| 0.0 |
0.2 |
GO:0045724 |
positive regulation of cilium assembly(GO:0045724) |
| 0.0 |
0.1 |
GO:0030836 |
positive regulation of actin filament depolymerization(GO:0030836) |
| 0.0 |
0.3 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.0 |
0.1 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.0 |
0.2 |
GO:0019348 |
dolichol metabolic process(GO:0019348) |
| 0.0 |
0.7 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.0 |
0.6 |
GO:0048147 |
negative regulation of fibroblast proliferation(GO:0048147) |
| 0.0 |
0.2 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.0 |
0.7 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 |
1.4 |
GO:0032436 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
| 0.0 |
0.8 |
GO:0061512 |
protein localization to cilium(GO:0061512) |
| 0.0 |
0.1 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.0 |
0.1 |
GO:2000672 |
regulation of motor neuron apoptotic process(GO:2000671) negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.0 |
0.5 |
GO:0000731 |
DNA synthesis involved in DNA repair(GO:0000731) |
| 0.0 |
0.5 |
GO:0060384 |
innervation(GO:0060384) |
| 0.0 |
0.4 |
GO:0010669 |
epithelial structure maintenance(GO:0010669) |
| 0.0 |
0.1 |
GO:0098789 |
pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.0 |
0.1 |
GO:0019243 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.0 |
0.1 |
GO:0006544 |
glycine metabolic process(GO:0006544) |
| 0.0 |
0.9 |
GO:1901998 |
toxin transport(GO:1901998) |
| 0.0 |
0.1 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.0 |
0.4 |
GO:0032456 |
endocytic recycling(GO:0032456) |
| 0.0 |
0.2 |
GO:0071218 |
cellular response to misfolded protein(GO:0071218) |
| 0.0 |
0.2 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.0 |
0.2 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.0 |
0.2 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.0 |
0.3 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.0 |
0.5 |
GO:0006110 |
regulation of glycolytic process(GO:0006110) |
| 0.0 |
0.1 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.0 |
0.2 |
GO:0021819 |
layer formation in cerebral cortex(GO:0021819) |
| 0.0 |
0.3 |
GO:0009072 |
aromatic amino acid family metabolic process(GO:0009072) |
| 0.0 |
0.5 |
GO:0034340 |
response to type I interferon(GO:0034340) |
| 0.0 |
0.2 |
GO:0036260 |
7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 0.0 |
0.2 |
GO:0003283 |
atrial septum development(GO:0003283) |
| 0.0 |
0.3 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.0 |
0.2 |
GO:0051057 |
positive regulation of small GTPase mediated signal transduction(GO:0051057) |
| 0.0 |
0.1 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.0 |
0.4 |
GO:0006970 |
response to osmotic stress(GO:0006970) |
| 0.0 |
0.0 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.0 |
0.1 |
GO:0016479 |
negative regulation of transcription from RNA polymerase I promoter(GO:0016479) negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.0 |
0.1 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.0 |
0.1 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 0.0 |
0.1 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.0 |
0.4 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 0.0 |
0.2 |
GO:0019886 |
antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
| 0.0 |
0.2 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.0 |
0.3 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.0 |
0.4 |
GO:0015813 |
L-glutamate transport(GO:0015813) |
| 0.0 |
0.3 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.0 |
0.1 |
GO:0050774 |
negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.0 |
0.5 |
GO:0030514 |
negative regulation of BMP signaling pathway(GO:0030514) |
| 0.0 |
0.1 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.0 |
0.1 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.0 |
0.0 |
GO:0032661 |
regulation of interleukin-18 production(GO:0032661) negative regulation of interleukin-18 production(GO:0032701) |
| 0.0 |
0.4 |
GO:0042462 |
eye photoreceptor cell development(GO:0042462) |
| 0.0 |
0.1 |
GO:0090220 |
meiotic telomere clustering(GO:0045141) chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
| 0.0 |
0.3 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.0 |
0.2 |
GO:0090263 |
positive regulation of canonical Wnt signaling pathway(GO:0090263) |
| 0.0 |
0.1 |
GO:1900864 |
mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.0 |
0.5 |
GO:0045668 |
negative regulation of osteoblast differentiation(GO:0045668) |
| 0.0 |
0.2 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.0 |
0.0 |
GO:0010626 |
negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.0 |
0.2 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.0 |
0.1 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
| 0.0 |
0.6 |
GO:0035303 |
regulation of dephosphorylation(GO:0035303) regulation of protein dephosphorylation(GO:0035304) |
| 0.0 |
0.0 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 0.0 |
0.6 |
GO:0035904 |
aorta development(GO:0035904) |
| 0.0 |
0.2 |
GO:0000266 |
mitochondrial fission(GO:0000266) |
| 0.0 |
0.0 |
GO:2000427 |
eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) T cell extravasation(GO:0072683) positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.0 |
0.0 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.0 |
0.4 |
GO:0030433 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.0 |
0.0 |
GO:0035552 |
oxidative single-stranded DNA demethylation(GO:0035552) |
| 0.0 |
0.1 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.0 |
0.1 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.0 |
0.4 |
GO:0032465 |
regulation of cytokinesis(GO:0032465) |
| 0.0 |
0.1 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
